The Cancer Risk Intake System (CRIS), a computerized program that ''matches'' objective cancer risks to appropriate risk management recommendations, was designed to facilitate patient-clinician discussion. We evaluated CRIS in primary care settings via a single-group, self-report, pretest-posttest design. Participants completed baseline telephone surveys, used CRIS during clinic visits, and completed followup surveys 1 to 2 months postvisit. Compared with proportions reporting having had discussions at baseline, significantly greater proportions of participants reported having discussed tamoxifen, genetic counseling, and colonoscopy, as appropriate, after using CRIS. Most (79%) reported CRIS had ''caused'' their discussion. CRIS is an easily used, disseminable program that showed promising results in primary care settings. ; there is support for focusing on patient-clinician discussions to encourage consideration of and participation in these behaviors.However, identifying which cancer risk management topics should be discussed is challenging and time consuming in primary care settings. Determining for whom surveillance, chemoprevention, or genetic counseling is appropriate involves consideration of multiple personal and familial factors that affect cancer risk and can thus be beyond clinicians' training or time constraints. For example, colon cancer surveillance guidelines are complex and require analysis of personal and familial risk to determine which test is recommended, when it should be initiated, and at what intervals to repeat it. 6 Appropriate chemoprevention recommendations involve assessment of risk, potential contraindications, and personal preferences. Whether a patient might benefit from genetic counseling is based on personal risk and family history. It is not surprising, then, that too few at-risk individuals receive cancer risk management recommendations. Appropriate referral for and participation in cancer genetic counseling is inconsistent 24,25 ; too few high-risk individuals are informed of the purpose and benefits of cancer genetic counseling.
26,27Not only is appropriate surveillance not achieved among individuals with elevated colorectal cancer risk, even their participation in routine screening is low. 22,28,29 We sought to develop a system for efficiently facilitating patient-clinician discussions about cancer risk and risk management. Our computerized Cancer Risk Intake System (CRIS) assesses personal health history and medical conditions, family cancer history, and other risk factors for breast, ovarian, and colorectal cancers; a complex set of CRIS algorithms then uses these data to generate, for individuals and primary care clinicians, printed information tailored by the patient's risk. If objective risk is high enough, the tailored printout includes recommendations to consider one or more of the following: breast cancer chemoprevention via tamoxifen, genetic counseling, and colon cancer surveillance.In this study, patients completed baseline surveys by phone prior to clinic visits,...